Effects of selenium and retinoic acid on the metabolism of N-acetylaminofluorene and N-hydroxyacetylamino-fluorene
- PMID: 99229
- DOI: 10.1016/s0304-3835(78)80045-7
Effects of selenium and retinoic acid on the metabolism of N-acetylaminofluorene and N-hydroxyacetylamino-fluorene
Abstract
Male albino rats were given 4 ppm selenium (Se(as Na2SeO3) in the water, or 0.25% retinoic acid was added to the basal diet for 3 days. Control and treated animals were given 17 mg acetylaminofluorene (AAF)-9-14C or N-hydroxyacetylaminofluorene (NOHAAF)-9-14C/kg body wt. The administration of Se enhanced glucuronyl transferase activity by 100% and inhibited p-nitrophenol-sulfotransferase by 50%. Retinoic acid enhanced the glucuronyl transferase 37% and inhibited the p-nitrophenol-sulfotransferase by 50%. Pretreatment with Se lowered levels of both AAF and NOHAAF in liver tissue by 30%. Se administration lowered the binding of the labeled carcinogens, or metabolites thereof, to the liver DNA and tRNA.
Similar articles
-
Selenium effects on the carcinogenicity and metabolism of 2-acetylaminofluorene.Cancer Lett. 1979 Oct;7(6):331-8. doi: 10.1016/s0304-3835(79)80062-2. Cancer Lett. 1979. PMID: 509411
-
Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.Cancer Lett. 1977 May;2(6):319-22. doi: 10.1016/s0304-3835(77)80011-6. Cancer Lett. 1977. PMID: 324608
-
Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.Cancer Res. 1979 Aug;39(8):3268-75. Cancer Res. 1979. PMID: 455309
-
Inhibition of sulfotransferase in primary cultures of human hepatocytes affecting metabolism and binding of 2-acetylaminofluorene.Cancer Lett. 1992 Jun 15;64(2):109-15. doi: 10.1016/0304-3835(92)90070-c. Cancer Lett. 1992. PMID: 1611593
-
Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts.Carcinogenesis. 1987 Mar;8(3):471-8. doi: 10.1093/carcin/8.3.471. Carcinogenesis. 1987. PMID: 3815742
Cited by
-
Selenium-mediated inhibition of mammary carcinogenesis.Biol Trace Elem Res. 1983 Aug;5(4-5):317-30. doi: 10.1007/BF02987217. Biol Trace Elem Res. 1983. PMID: 24263570
-
Immune responses in rats supplemented with selenium.Clin Exp Immunol. 1986 Mar;63(3):570-6. Clin Exp Immunol. 1986. PMID: 3486734 Free PMC article.
-
The two faces of selenium-deficiency and toxicity--are similar in animals and man.Can J Vet Res. 1986 Jul;50(3):297-306. Can J Vet Res. 1986. PMID: 3527390 Free PMC article. Review.
-
Stage specificity of selenium-mediated inhibition of mouse mammary tumorigenesis.Biol Trace Elem Res. 1983 Aug;5(4-5):297-306. doi: 10.1007/BF02987215. Biol Trace Elem Res. 1983. PMID: 24263568
-
Different effects of selenium on cyclic AMP metabolism in hepatoma cells and normal liver cells.Biol Trace Elem Res. 1983 Feb;5(1):9-16. doi: 10.1007/BF02916922. Biol Trace Elem Res. 1983. PMID: 24263364
MeSH terms
Substances
LinkOut - more resources
Full Text Sources